India's Services PMI Turns — Now the Question Is Which IT Name Actually Earns It

India's Services PMI Turns — Now the Question Is Which IT Name Actually Earns It

India's flash PMI data released today carries a simple headline: private sector growth improved in August as the services sector strengthened, while manufacturing eased to 52.9 — its weakest reading in 60 months. The composite moved higher from July's 54.3, when both segments had printed near multi-year lows.

For investors who track IT services through US-listed names, the macro signal is directionally clear after months of fading client appetite and fierce competition that dragged the July services PMI to 53.3, its lowest level since early 2022. A turnaround in Indian services activity matters because large Indian IT firms — and their US-listed counterparts that rely heavily on offshore delivery — typically feel the domestic demand cycle within one to two quarters.

But the PMI headline alone doesn't tell you which stock to buy. The factor stack does.

Cognizant (CTSH) and IBM are the two US-listed IT services names where we can run a full five-factor read across valuation, growth, profitability, safety, and momentum today. One of them looks like a recovery play with room to run. The other is showing the kind of factor erosion that a rally can't disguise. Let's walk through the comparison.

CTSH: The Cheap Rebound Play

Valuation — A. Cognizant trades at 10.5 times forward earnings and 7.0 times EV/EBITDA. You can't buy US-listed IT services at those multiples anywhere else. Revenue growth is modest at 5.6% year over year, but free cash flow growth has accelerated to 13.9% and margins are holding — operating margin at 15.8%, FCF margin at 11.5%.

Growth — C+. Revenue growth is real but not fast. 5.6% year-over-year tells you the company is not in trouble, but it isn't in a tear either. The FCF growth outpacing revenue growth by nearly 8 percentage points suggests operating leverage is kicking in. That's the kind of divergence that starts to matter when client spending normalizes.

Profitability — B. An ROIC of 13.5% and ROE of 14.9% are solid for a services business. Gross margin sits at 33.5%, which is thin by software standards but competitive within the IT services set. Operating margin at 15.8% has held steady despite the softening client environment of 2025-2026, which suggests pricing power hasn't been structurally damaged.

Safety — A+. This is the standout factor. Debt-to-equity is just 10.8%, the current ratio is 218%, and net debt is only $509 million on $1.0 billion in cash. Free cash flow hit $2.6 billion over the trailing twelve months. In an IT services company where the business model is people-heavy and capital-light, this balance sheet gives management room to invest through the cycle, buy back shares, or pursue bolt-on M&A without stress.

Momentum — B+ (with a caution). The stock is up 41.6% over the past 20 days and is trading at $60.92. The 50-day moving average is at $48.81, well below the current price. But RSI has climbed to 70.7 — entering overbought territory — and the 200-day MA sits at $63.32, just above. The short-term move is real, but the pace puts it at a technical inflection point.

The portfolio role: CTSH is a growth sleeve play on the services recovery, positioned to benefit if Indian and global IT demand normalizes. The 2.2% dividend yield adds some cushion. The trigger to tighten would be a break back below the 50-day MA at $48.81, which would signal the rally lost structural support.

IBM: The Factor Erosion Story

Valuation — D+. At 33.9 times forward earnings and 15.9 times EV/EBITDA, IBM is expensive for an IT services and infrastructure name. The PEG ratio reads 0.25, but that's a mirage — forward earnings of $6.90 per share (implied from the 33.9x multiple on $233.69) already bake in significant cost-cutting and hybrid cloud growth. The trailing PE of 20.5 looks more honest.

Growth — B. Revenue growth of 7.9% year over year is genuinely good — better than CTSH's 5.6%. But the question is durability. Gross profit growth tracks revenue at 8.9%, which is consistent. FCF growth of 12.9% is strong. The problem isn't the current growth rate; it's whether 33.9x forward earnings can sustain the implied trajectory.

Profitability — A. This is IBM's strongest factor. ROIC of 13.1% is competitive. ROE of 34.6% is exceptional but comes with a loaded denominator — total equity of just $34.5 billion against $220 billion in market cap, thanks to aggressive share buybacks compressing the equity base. Operating margin of 17.5% and EBITDA margin of 24.9% are class-leading. Gross margin at 58.4% reflects the high-margin consulting and software mix.

Safety — C-. Here the picture gets unattractive. Total debt sits at $117.6 billion with only $7.2 billion in cash, for net debt of $53.9 billion. Debt-to-equity is 179.5%. The current ratio is 79.1%, below 1.0 — meaning current liabilities exceed current assets. Free cash flow of $13.1 billion TTM covers interest payments comfortably, but the leverage is structural, not cyclical. This is a company funded by its own cash flow machine, and the machine has to keep running.

Momentum — D. IBM is trading at $233.69, below both the 50-day MA of $248.09 and the 200-day MA of $266.35. RSI sits at 47.9, slightly below the midpoint, and MACD is negative at -2.28. The stock is down 21.1% year-to-date and -3.7% on a rolling 12-month basis. The 20-day rally of 13.1% looks like a dead-cat bounce relative to the 52-week range of $199 to $332.

The portfolio role: IBM works only as an income name — 2.9% dividend yield with 24 consecutive years of payments and 23 years of dividend growth. But the factor stack doesn't support aggressive positioning. It's a hold, not a buy, unless valuation compresses further or the forward multiple drops toward the 20x range.

The Comparison That Matters

Factor	CTSH	IBM
Valuation	10.5x forward PE	33.9x forward PE
Revenue Growth	5.6%	7.9%
FCF Growth	13.9%	12.9%
ROIC	13.5%	13.1%
Debt/Equity	10.8%	179.5%
RSI	70.7 (overbought)	47.9 (neutral)
YTD Return	Not available	-21.1%

The India PMI data gives you the directional theme — services are turning. The factor comparison tells you which name actually earns it. CTSH offers the better entry point on valuation, a dramatically safer balance sheet, and momentum that has already started to price in the recovery. IBM offers better current revenue growth and higher margins, but at a multiple that assumes perfection and a balance sheet that requires it.

The risk to the CTSH case is straightforward: RSI at 70.7 means the stock has run fast, and if global IT demand doesn't follow the Indian PMI lead, the move unwinds. The risk to IBM is structural — if the cash flow machine stutters, a 179.5% debt-to-equity ratio with a sub-1.0 current ratio creates real stress.

The process says: CTSH is a buy-and-manage position in the growth sleeve, sized modestly given the momentum read. IBM is a hold for income investors already in it, not a new position. The India services PMI is the catalyst you've been watching. The factor stack tells you where to allocate.